CSL's R&D in Switzerland
Innovation is in Our DNA
Investment in R&D is an important driver for CSL’s growth. We continue to build on our capabilities across the R&D value chain, from discovery research to pharmacovigilance to our currently marketed therapies. Such proficiency is critical as R&D builds the novel and diverse pipeline of the future. Learn more by visiting CSL.com.
Our R&D in Switzerland
Our Swiss subsidiary was founded in 1949 by the Swiss Red Cross in Bern. Today, we operate as one integrated global R&D organization. To contribute to achieving our global strategic goals, we are strategically locating our R&D capabilities in Switzerland in the greater Zurich biotech ecosystem, harnessing access to an excellent talent pool and external innovation opportunities. By doing so, we are creating the right environment for teams to thrive and innovation to flourish—while staying focused on delivering better outcomes for patients worldwide.